2931 Stock Overview
Engages in the research, development, production, and sale of microalgae in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Euglena Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥435.00 |
| 52 Week High | JP¥799.00 |
| 52 Week Low | JP¥394.00 |
| Beta | 0.064 |
| 11 Month Change | 1.16% |
| 3 Month Change | -14.20% |
| 1 Year Change | -44.87% |
| 33 Year Change | -52.77% |
| 5 Year Change | -45.15% |
| Change since IPO | 178.13% |
Recent News & Updates
Shareholder Returns
| 2931 | JP Personal Products | JP Market | |
|---|---|---|---|
| 7D | -4.2% | -3.7% | -1.8% |
| 1Y | -44.9% | -10.1% | 11.4% |
Return vs Industry: 2931 underperformed the JP Personal Products industry which returned -10.1% over the past year.
Return vs Market: 2931 underperformed the JP Market which returned 11.4% over the past year.
Price Volatility
| 2931 volatility | |
|---|---|
| 2931 Average Weekly Movement | 5.7% |
| Personal Products Industry Average Movement | 3.7% |
| Market Average Movement | 3.9% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 2931's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 2931's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 846 | Tomohiro Wakahara | www.euglena.jp |
Euglena Co., Ltd. engages in the research, development, production, and sale of microalgae in Japan. It also manufactures and sells foods and cosmetics using euglena. In addition, the company develops biofuel technology and environmental related technology for microalgae; and invests in biotechnology related business.
Euglena Co., Ltd. Fundamentals Summary
| 2931 fundamental statistics | |
|---|---|
| Market cap | JP¥57.69b |
| Earnings (TTM) | -JP¥2.44b |
| Revenue (TTM) | JP¥47.68b |
1.2x
P/S Ratio-24.3x
P/E RatioIs 2931 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2931 income statement (TTM) | |
|---|---|
| Revenue | JP¥47.68b |
| Cost of Revenue | JP¥14.74b |
| Gross Profit | JP¥32.93b |
| Other Expenses | JP¥35.37b |
| Earnings | -JP¥2.44b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -17.87 |
| Gross Margin | 69.08% |
| Net Profit Margin | -5.11% |
| Debt/Equity Ratio | 85.2% |
How did 2931 perform over the long term?
See historical performance and comparison